Experts call for easing access to 2mg and 4mg nicotine replacement therapies
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
Leading orthopaedic experts call for equitable insurance coverage to patients for accessing advanced, precision-driven joint replacement technologies
The event also featured discussions on emerging trends in joint replacement surgery
Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
The acquisition marks the company’s strategic entry into the fast-growing Hormone Replacement Therapy (HRT) segment and significantly strengthens its gynaecology portfolio in India
The SAPIEN M3 transcatheter mitral valve replacement (TMVR) system is designed for patients with symptomatic moderate-to-severe or severe MR
The initiative is focused on a problem that continues to plague cancer outcomes in India
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
Replicate will receive research funding and could potentially receive up to approximately US$550 million
Peter Bains has over three decades of experience in the biotech and pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated